Immunostimulatory effect of synthetic oligonucleotide in human lung cancer

Immunostimulatory effect of synthetic oligonucleotide in human lung cancer - ODN in human lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027609

Enrollment

Registered

2017-06-03

Start date

2017-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1) Patients who can provide 16ml of peripheral blood or 50ml of pleural effusion 2) 20 years and older 3) Patients enable to informed consent in document

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1) Patients with untreated mental disorder 2) Patients who judged as inappropriate for this study by the attending physician

Design outcomes

Primary

Measure	Time frame
1.Cell proliferation assay 2.Intra-cellular IFN gamma assay 3.Cytokine production (ELISA, ELISPOT, real-time PCR)	—

Countries

Japan

Contacts

Public ContactNobuaki Kobayashi

Yokohama City University Medical Center Center for Respiratory Disease

nkobayas@yokohama-cu.ac.jp045-261-5656

Outcome results